
News|Articles|November 18, 2025
ADA Assays for Complex Molecule Development
Author(s)Prolytix
Having a robust immunogenicity assay for accurate evaluation of ADA in animal models is important for enabling effective decision-making during development. Learn how a robust anti-drug antibody assay was developed and was capable of detection at the requisite sensitivity and enabled meaningful interpretation of PK data obtained from the preclinical animal model.
Trending on Pharmaceutical Technology
1
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
2
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
3
Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5